Current guidelines recommend that physicians use a shared decision-making (SDM) approach to engage with patients on the potential benefits and harms of prostate cancer screening based on their individual risk. In a sample of 4,118 men aged 55–69 from the 2018 New York State Behavioral Risk Factor Surveillance Survey (BRFSS), we compared the frequency of screening recommendations and SDM conversations according to four race/ethnic groups. In logistic regression, we evaluated the likelihood of SDM conversations between race/ethnic groups. Our findings suggest that the odds of never having a SDM conversation with their healthcare provider were significantly higher among Hispanic men (OR 95% CI: 2.10, 1.11–3.99) and other/multiracial men (OR, 95% CI: 3.08, 1.46–6.52) compared to white men, while black men had comparable odds (1.52, 0.98–2.34). The lower frequency of SDM conversation among Hispanic and other/multiracial men suggest a missed opportunity for healthcare providers to guide informed screening decisions.
This is a preview of subscription content,to check access.
Access this article
Brawley OW. Trends in prostate cancer in the United States. J Natl Cancer Inst Monogr. 2012;2012(45):152–6.
Madduri SD. USPSTF Update of Guidelines on early detection of prostate Cancer. Mo Med. 2018;115(4):337.
Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: U.S. Department of Health and Human Services,Centers for Disease Control and Prevention, 2018.
Cooper DL, et al. Are men making informed decisions according to the prostate-specific Antigen Test Guidelines? Analysis of the 2015 behavioral risk factor Surveillance System. Am J Mens Health. 2019;13(2):1557988319834843.
Hoffman RM, et al. Prostate cancer screening decisions: results from the National Survey of Medical decisions (DECISIONS study). Arch Intern Med. 2009;169(17):1611–8.
Rutten LJF, et al. Factors associated with men’s use of prostate-specific antigen screening: evidence from Health Information National Trends Survey. Prev Med. 2005;40(4):461–8.
Han PK, et al. National evidence on the use of shared decision making in prostate-specific antigen screening. Ann Fam Med. 2013;11(4):306–14.
U.S. Cancer Statistics Working Group. U.S. Cancer Statistics Data Visualizations Tool, based on 2021 submission data (1999–2019): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; www.cdc.gov/cancer/dataviz, released in June 2022.
No financial support was received for this work. No copyrighted materials/surveys/instruments/tools were used in this work.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Mattick, L.J., Biney, K., Dacus, H.M. et al. Prevalence of Shared Decision-making in Prostate Cancer Screening in New York State. J Immigrant Minority Health 25, 1207–1210 (2023). https://doi.org/10.1007/s10903-023-01482-5